Headlines
Bloomberg MarketsWarsh Rocks Bond Market in Debut, Sparks Surge in Rate-Hike BetsBloomberg MarketsAsian Stocks, Bonds to Fall on Hawkish Fed Signals: Markets WrapBloomberg MarketsHighlights From Fed Chair Warsh’s First News ConferenceBloomberg MarketsCrude Oil Edges Lower as Deal to Reopen Hormuz Goes Into EffectBloomberg MarketsChef Kwame Onwuachi on New Las Vegas Restaurant, TatianaBloomberg MarketsBloomberg Surveillance: The Fed Decides 6/17/2026Bloomberg MarketsWarsh Says FOMC Had 'Good Family Fight' on Fed Policy as Rates Stay SteadyBloomberg MarketsBarings’ High-Yield Playbook in a Warsh-Led Fed EraBloomberg Markets【今朝の5本】仕事を始める前に読んでおきたい厳選ニュースBloomberg MarketsTrump Says US, Israel Have 'Little Dispute Over Lebanon'Financial TimesFed officials tilt towards rate rise as Kevin Warsh era beginsBloomberg MarketsBOJ Will Hike Rates Again by December, Says 90% of EconomistsBloomberg MarketsFmr. Fed Vice Chair Blinder on FOMC Decision, InflationBloomberg MarketsBlackRock's Rosenberg Warns About Overplaying the Flattening Yield CurveBloomberg MarketsOaktree Private Credit Fund Redemptions Drop Below Key 5% LimitBloomberg MarketsWarsh Rocks Bond Market in Debut, Sparks Surge in Rate-Hike BetsBloomberg MarketsAsian Stocks, Bonds to Fall on Hawkish Fed Signals: Markets WrapBloomberg MarketsHighlights From Fed Chair Warsh’s First News ConferenceBloomberg MarketsCrude Oil Edges Lower as Deal to Reopen Hormuz Goes Into EffectBloomberg MarketsChef Kwame Onwuachi on New Las Vegas Restaurant, TatianaBloomberg MarketsBloomberg Surveillance: The Fed Decides 6/17/2026Bloomberg MarketsWarsh Says FOMC Had 'Good Family Fight' on Fed Policy as Rates Stay SteadyBloomberg MarketsBarings’ High-Yield Playbook in a Warsh-Led Fed EraBloomberg Markets【今朝の5本】仕事を始める前に読んでおきたい厳選ニュースBloomberg MarketsTrump Says US, Israel Have 'Little Dispute Over Lebanon'Financial TimesFed officials tilt towards rate rise as Kevin Warsh era beginsBloomberg MarketsBOJ Will Hike Rates Again by December, Says 90% of EconomistsBloomberg MarketsFmr. Fed Vice Chair Blinder on FOMC Decision, InflationBloomberg MarketsBlackRock's Rosenberg Warns About Overplaying the Flattening Yield CurveBloomberg MarketsOaktree Private Credit Fund Redemptions Drop Below Key 5% Limit
Home/Bloomberg Markets
Back
MARKETS:
SPY+0.26%
DIA+0.23%
QQQ-0.14%
IWM+0.29%
GLD-0.40%
USO+1.64%
Bloomberg Marketsglobal

J&J Has No Plans to Enter Obesity Drugs Market, CEO Says

Bloomberg Markets
Wednesday, June 17, 2026 at 7:37 PM
~4 min read

Original Report

Johnson & Johnson has no plans to enter the booming obesity market, opting instead to focus on diseases such as cancer, CEO Joaquin Duato said in an interview for an upcoming episode of The David...

Johnson & Johnson has no plans to enter the booming obesity market, opting instead to focus on diseases such as cancer, CEO Joaquin Duato said in an interview for an upcoming episode of The David Rubenstein Show: Peer to Peer Conversations. The comments set J&J apart from many of its rivals that are trying to develop or acquire obesity medicines following blockbuster weight-loss drugs from Eli Lilly & Co. and Novo Nordisk. (Source: Bloomberg)

Glass House Analysis

Corporate decisions reverberate through local communities—a merger might mean headquarters relocating, a restructuring could eliminate jobs, and strategic shifts affect suppliers and service providers in countless towns. Behind quarterly earnings numbers are real employment decisions, investment choices, and community impacts that shape the economic landscape of regions across the country.

The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.

Enjoyed this analysis?

Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.

No spam. Unsubscribe anytime.

More Stories

Economic Context

S&P 500
+0.26%
Dow Jones
+0.23%
NASDAQ 100
-0.14%
Russell 2000
+0.29%